Lonza and Chr. Hansen in JV to accelerate momentum in Microbiome
COPENHAGEN: Chr. Hansen Holding A/S, a leading global bioscience company, and Lonza AG, a leading pharma contract manufacturing company, have signed an agreement to establish a 50/50joint venture to pioneer…